Strong Zytiga study results could increase uptake
March 12, 2012Research and Development, Sales and Marketing IDMC, Janssen, Provenge, Zytiga, prostate
Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …
Sanofi launches iPhone and iPod glucose monitor in the UK
March 12, 2012Medical Communications, Sales and Marketing BGStar, Sanofi, diabetes, iPod, iphone
Sanofi has launched a new diabetes device in the UK to help patients monitor their blood sugar levels from their …
Patheon swings to loss on terminated manufacturing contract
March 12, 2012Manufacturing and Production Patheon, fiscal, manufacturing, operating
Contract manufacturing and development organisation Patheon said it posted an operating loss in its fiscal first quarter results after losing …
UCB chief executive to chair IMI
March 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB
UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …
Prescription drugs could become OTC under FDA plans
March 12, 2012Sales and Marketing COPD, FDA, OTC, prescribing
The FDA is considering new plans to make drugs for chronic conditions available over-the-counter. These drugs could include medicines for …
India’s Nexavar patent ruling disturbs pharma
March 12, 2012Sales and Marketing India, emerging markets, intellectual property, patents
India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …
Government could be forced to publish risk register
March 9, 2012Sales and Marketing Healey, NHS, reforms, risk
The government has lost its appeal to keep details about the risks involved in the reform of the NHS secret. …
Major new drugs for 2012
March 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Caprelsa, Eylea, Manjor new drugs, Xalkori, Zelboraf, avastin, inlyta
Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …
Battle against prostate cancer gains celebrity endorsement
March 9, 2012Medical Communications M&S, MS, Vader, prostate
A famous DJ and a legendary Star Wars actor have joined forces to raise awareness of prostate cancer. Star Wars …
inVentiv appoints former Quintiles man Mark Archer
March 9, 2012Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv
Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …
Government touts telehealth scheme
March 9, 2012Medical Communications, Sales and Marketing NHS, king's fund, telecare, telehealth
The government has said that telehealth and telecare technology could save the NHS £1.2 billion over the next five years. …
New website launched to help people with psoriasis
March 9, 2012Medical Communications 360. PM soc, Twitter, psoriasis
A new online resource for patients with psoriasis has been set up to help them understand and manage their disease. …
NICE recommends Victrelis in speedy review
March 9, 2012Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis
NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review. In its final …
Aurora bolsters senior team with new director
March 8, 2012Business Services, Medical Communications, Sales and Marketing Aurora, LoweFusion, Pan
Aurora has appointed Rachel Terry as its new director.Terry was previously director of healthcare at Burson-Marsteller until the end of …
Synthes plant cited in FDA warning letter
March 8, 2012Manufacturing and Production FDA, J&J, JJ, Synthes, manufacturing
The US FDA has sent a warning letter to surgical equipment manufacturer Synthes upbraiding it for deficiencies at a manufacturing …
Boehringer censured over Pradaxa website
March 8, 2012Medical Communications ABPI, Boehringer Ingelheim, PMCPA, Pradaxa
Boehringer Ingelheim has breached the ABPI’s Code of Conduct over the use of its Pradaxa website. Pradaxa is a …
Keep Alzheimer’s patients on Aricept for longer, study says
March 8, 2012Research and Development, Sales and Marketing Aricept, Pfizer, Teva, donepezil
Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
Biotec launches new operational facilities and increases temperature controlled storage
March 8, 2012Manufacturing and Production
UK based pharmaceutical services business Biotec Services International has launched a dedicated new storage and operational facility along with upgraded …
Novartis Indian patent battle nears conclusion
March 7, 2012Sales and Marketing Glivec, HIV, India, Novartis, patents
A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …
Pfizer’s virtual trial fails in recruitment drive
March 7, 2012Medical Communications Pfizer, bladder, virtual clinic, youtube
The world’s first ‘virtual’ clinic has failed to recruit patients in the US, representing a major blow to Pfizer. The …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
